Familial hypercholesterolemia

Victoria Enchia Bouhairie, Anne Carol Goldberg

Research output: Contribution to journalReview articlepeer-review

58 Scopus citations


Familial hypercholesterolemia is a common, inherited disorder of cholesterol metabolism that leads to early cardiovascular morbidity and mortality. It is underdiagnosed and undertreated. Statins, ezetimibe, bile acid sequestrants, niacin, lomitapide, mipomersen, and low-density lipoprotein (LDL) apheresis are treatments that can lower LDL cholesterol levels. Early treatment can lead to substantial reduction of cardiovascular events and death in patients with familial hypercholesterolemia. It is important to increase awareness of this disorder in physicians and patients to reduce the burden of this disorder.

Original languageEnglish
Pages (from-to)169-179
Number of pages11
JournalCardiology clinics
Issue number2
StatePublished - May 1 2015


  • Bile acid sequestrants
  • Ezetimibe
  • Familial hypercholesterolemia
  • LDL apheresis
  • Lomitapide
  • Mipomersen
  • Statins


Dive into the research topics of 'Familial hypercholesterolemia'. Together they form a unique fingerprint.

Cite this